Jt Stratford LLC Gilead Sciences, Inc. Transaction History

Jt Stratford LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $33,243 - $37,874	430 Added 3.11%	14,271 $1.18 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $862,571 - $1.24 Million	13,841 New	13,841 $1.19 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $825,447 - $940,558	-14,571 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $136,433 - $171,541	-2,197 Reduced 13.1%	14,571 $921,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $122,182 - $141,876	-1,689 Reduced 9.15%	16,768 $1.29 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $1.16 Million - $1.48 Million	18,457 New	18,457 $1.38 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

Stay updated on Jt Stratford LLC with notifications on news.